DXCM logo

DexCom Inc (DXCM)

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system;...

NASDAQHealthcareMedical DevicesUSA

Company Profile

Stock Code
DXCM
ISIN Code
US2521311074
Currency
US Dollar (USD)
IPO Date
2005-04-14

Contact Information

Company Address
6340 Sequence Drive, San Diego, CA, United States, 92121
Contact Phone
858 200 0200
Company Website
https://www.dexcom.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Return on Assets (TTM)
9.65%
EBITDA
$999,999.99
Revenue (TTM)
$999,999.99